Canada markets closed

Matricelf Ltd (MTRLF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.90000.0000 (0.00%)
At close: 02:27PM EDT

Matricelf Ltd

Golda Meir 3
Ness Ziona
Israel
972 50 405 7353
https://www.matricelf.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Alon SinaiFounder, CEO & DirectorN/AN/A1967
Prof. Tal Dvir Ph.D.Co-Founder, CSO & DirectorN/AN/AN/A
Ms. Sigal Russo-GuetaChief Financial OfficerN/AN/A1978
Tal Ben NeriahVP of OperationsN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Matricelf Ltd, a biotechnology company, develops a platform for autologous matrix and cells implants for various medical conditions. Its regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson's disease, and myocardial infarction, as well as for 3D organ printing. Matricelf Ltd was founded in 2019 and is based in Ness Ziona, Israel.

Corporate Governance

Matricelf Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.